We are looking for easy to use, accessible, reliable & actionable diagnostic solutions that enhance early detection and condition awareness. Our focus is on delivering to our consumers user-friendly, reliable, easily accessible and actionable diagnostic solutions in the following areas:​

• Liver health – supporting condition awareness for NAFLD/MAFLD​
• Allergy – aiding in diagnosis, prevention, and treatment​
• Gut health – including actionable microbiome analysis​

​
Our goal is to ensure that users can understand the why and how, feel motivated to take action, and clearly observe the impact of the actions taken.​

We believe healthtech can unlock the power of self-care by enabling condition awareness and informed decision-making. Our goal is to empower consumers with accurate, accessible, and actionable information—especially for silent diseases and complex conditions where symptoms are hard to trace back to their root causes.​
​
This approach supports:​

• Prevention & Early Intervention – Giving consumers and healthcare providers the tools to reduce risks and manage conditions before they become severe.​
• Faster, More Effective and More Personalized Treatment – Delivering quicker, more effective, and tailored treatment options that improve outcomes.​
• Proven Results – Offering solutions backed by real-world data and measurable impact.​

Must-have Requirements.

• At-home and point-of-care diagnostics​
• Non-Invasive tests or minimally invasive​
• Instant diagnostics with real-time results​
• High sensitivity to key biomarkers for accurate detection of health conditions and/or monitoring of progress and treatment response​
• Strong clinical and scientific evidence supporting the Diagnostic device​
• Compliance with medical device regulations and quality standards​
• Proprietary technology or intellectual property​

Preferred Requirements. ​

• At or near industrialization stage, with validated regulatory and quality compliance​
• Standalone diagnostic capability, providing comprehensive results that minimize the need for follow-up with a doctor​
• Validated product-market fit​
• Low cost for high accessibility, with a design optimized for low cost of goods (COGS) to ensure competitive pricing​

Approaches​ not of interest.

• Invasive tests​
• Standard Stool tests​
• Deferred analysis (at-home or point-of-care sampling with remote lab processing)​
• Rx products​

Target Group​.

These healthtech solutions can serve diverse audiences/users including:​

• Consumer-facing (children and adults), and​
• HCP-facing​

Geographies​.

Global